Hypoplastic Left Heart Syndrome (HLHS) is a rare congenital heart defect that affects the left side of the heart, resulting in underdevelopment of the left ventricle and other structures. It is estimated to occur in approximately 2 to 3 out of every 10,000 live births. While the exact cause of HLHS is unknown, it is believed to be a combination of genetic and environmental factors.
HLHS is a complex and life-threatening condition that requires immediate medical intervention. Without treatment, it is typically fatal within the first few days or weeks of life. Treatment options for HLHS include a series of surgeries, such as the Norwood procedure, to reroute blood flow and improve heart function.
Due to advancements in medical technology and improved surgical techniques, the survival rate for infants with HLHS has significantly improved over the years. However, managing HLHS remains challenging, and long-term outcomes can vary. Close monitoring and ongoing medical care are essential for individuals with HLHS throughout their lives.
While HLHS is relatively rare, its impact on affected individuals and their families is profound. Increased awareness, early detection, and access to specialized care are crucial in improving outcomes for those living with this complex heart condition.